Pharmacokinetics of lamotrigine in paediatric and young adult epileptic patients—nonlinear mixed effects modelling approach

Drug Interactions with the Newer Antiepileptic Drugs (AEDs)—Part 1: Pharmacokinetic and Pharmacodynamic Interactions Between AEDs

(2013) Philip N. Patsalos   CLINICAL PHARMACOKINETICS

Influence of Concomitant Antiepileptic Drugs on Plasma Lamotrigine Concentration in Adult Japanese Epilepsy Patients

(2012) Yoshiaki Yamamoto et al.   BIOLOGICAL & PHARMACEUTICAL BULLETIN

Population pharmacokinetics of lamotrigine in Indian epileptic patients

(2012) Surulivelrajan Mallaysamy et al.   EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY

Impact of age, weight and concomitant treatment on lamotrigine pharmacokinetics

(2012) B. B. Brzaković et al.   JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS

The effect of age and comedication on lamotrigine clearance, tolerability, and efficacy

(2011) Hiba Arif et al.   EPILEPSIA

The relationship between UGT1A4 polymorphism and serum concentration of lamotrigine in patients with epilepsy

(2011) Medine Idrizoglu Gulcebi et al.   EPILEPSY RESEARCH

The influence of drug–drug interaction and patients’ characteristics on valproic acid's clearance in adults with epilepsy using nonlinear mixed effects modeling

(2009) Katarina Vučićević et al.   EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES

Drug interactions involving the new second- and third-generation antiepileptic drugs

(2009) Cecilie Johannessen Landmark et al.   Expert Review of Neurotherapeutics

Antiepileptic drugsbest practice guidelines for therapeutic drug monitoring: A position paper by the subcommission on therapeutic drug monitoring, ILAE Commission on Therapeutic Strategies

(2008) Philip N. Patsalos et al.   EPILEPSIA